Recent advances in the management of locally advanced head and neck squamous cell carcinoma
10.3760/cma.j.cn113030-20230425-00095
- VernacularTitle:局部晚期头颈部鳞癌治疗进展
- Author:
Xinglong YANG
1
;
Xinhong LI
Author Information
1. 内蒙古医科大学附属医院，呼和浩特 010059
- Keywords:
Squamous cell carcinoma of head and neck, locally advanced;
Induction chemotherapy;
Immunotherapy;
Inhibitors of apoptosis protein;
Radiotherapy
- From:
Chinese Journal of Radiation Oncology
2024;33(1):72-78
- CountryChina
- Language:Chinese
-
Abstract:
Currently, concurrent chemoradiotherapy is the conventional treatment for locally advanced head and neck squamous cell carcinoma, but the 5-year survival rate of patients is still not high. In recent years, the development of radiotherapy technology has offered more options for patients. In addition, with the improvement of people's living standards, more and more patients begin to pursue the quality of life. There is an urgent need to explore better comprehensive treatment options to improve patient outcomes. In this article, research progress in comprehensive treatment of locally advanced head and neck squamous cell carcinoma was reviewed.
